Direkt zum Inhalt
Merck
  • Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats.

Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats.

Endocrine (2014-04-23)
Svetlana Trifunović, Milica Manojlović-Stojanoski, Vladimir Ajdžanović, Nataša Nestorović, Nataša Ristić, Ivana Medigović, Verica Milošević
ZUSAMMENFASSUNG

The hypothalamic-pituitary somatotropic system plays a pivotal role in the regulation of physiological processes and metabolism, which is modulated by gonadal steroids. Considering that genistein belongs to the phytoestrogen family and acts via similar mechanisms to estrogens, the present study was designed to demonstrate whether genistein modulates the morphofunctional characteristic of somatotrophs [growth hormone (GH) cells] in adult rats in comparison with the effects of estradiol. In the study, the orchidectomized adult rats were used as an appropriate model system for testing the effects of this hormone-like substance. Changes in the pituitary somatotrophs were evaluated histologically and stereologically, while GH level was determined biochemically. Using immunolabelling and stereological methods, we showed that orchidectomy (Orx) provoked the decrease of GH cell volume density. After estradiol treatment of Orx rats, the most prominent change concerned the pituitary relative intensity of GH fluorescence and circulating GH level, which were elevated 77 % and 4.7-fold, respectively. Clearly, in contrast to orchidectomy, estradiol treatment enhanced the GH cells activity. Genistein treatment increased pituitary weight and volume, GH cell volume density, the total number of GH cells, and GH blood concentration (1.3-fold) in comparison to the Orx group. Although identical tendencies followed estradiol and genistein administration, the changes observed after genistein treatment were milder compared to estradiol treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Calciumcarbonat, ACS reagent, ≥99.0%, powder
Sigma-Aldrich
Calciumcarbonat, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E170, precipitated, 98.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
β-tri-Calcium-phosphat, puriss. p.a., ≥98% β-phase basis (sintered Powder)
Sigma-Aldrich
Calciumcarbonat, powder, ≤50 μm particle size, 98%
Sigma-Aldrich
Calciumcarbonat, ReagentPlus®
Sigma-Aldrich
DL-Methionin, ≥99%
Sigma-Aldrich
β-tri-Calcium-phosphat, puriss. p.a., ≥98% β-phase basis (unsintered powder)
Sigma-Aldrich
Calciumcarbonat, 99.999% trace metals basis
Sigma-Aldrich
Calciumcarbonat, ACS reagent, chelometric standard, 99.95-100.05% dry basis
Sigma-Aldrich
Calciumcarbonat, BioReagent, suitable for insect cell culture, ≥99.0%
Sigma-Aldrich
Calciumcarbonat, ≥99.995% trace metals basis
USP
Calciumcarbonat (AS), United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Calciumcarbonat, BioUltra, precipitated, ≥99.0% (KT)
Supelco
Calciumcarbonat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Calciumcarbonat, reference material for titrimetry, certified by BAM, ≥99.5%
Sigma-Aldrich
Calciumcarbonat, BioXtra, ≥99.0%
Sigma-Aldrich
DL-Methionin, 99%, FCC, FG
Sigma-Aldrich
DL-Methionin, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Methionin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
DL-Methionin, ≥99.0% (NT)
Sigma-Aldrich
Calciumcarbonat, tested according to Ph. Eur.
Sigma-Aldrich
αβ-Tri-Calciumphosphat, Reagent for transient & stable DNA transfections
DL-Methionin, European Pharmacopoeia (EP) Reference Standard